These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3554348)

  • 1. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 3. The functional organization of the basal forebrain cholinergic system in primates and the role of this system in Alzheimer's disease.
    Price DL; Cork LC; Struble RG; Whitehouse PJ; Kitt CA; Walker LC
    Ann N Y Acad Sci; 1985; 444():287-95. PubMed ID: 3160283
    [No Abstract]   [Full Text] [Related]  

  • 4. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 5. The cholinergic hypothesis: a historical overview, current perspective, and future directions.
    Bartus RT; Dean RL; Pontecorvo MJ; Flicker C
    Ann N Y Acad Sci; 1985; 444():332-58. PubMed ID: 2990293
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
    Perry EK; Curtis M; Dick DJ; Candy JM; Atack JR; Bloxham CA; Blessed G; Fairbairn A; Tomlinson BE; Perry RH
    J Neurol Neurosurg Psychiatry; 1985 May; 48(5):413-21. PubMed ID: 3998751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular forms of acetylcholinesterases in Alzheimer's disease.
    Younkin SG; Goodridge B; Katz J; Lockett G; Nafziger D; Usiak MF; Younkin LH
    Fed Proc; 1986 Dec; 45(13):2982-8. PubMed ID: 2430839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
    Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and the new neuroscience.
    Wortis J
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic controversies.
    Perry EK; Irving D; Perry RH
    Trends Neurosci; 1991 Nov; 14(11):483-4; author reply 485-6. PubMed ID: 1726763
    [No Abstract]   [Full Text] [Related]  

  • 12. The morphological basis of dementia in Parkinson's disease.
    Ball MJ
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):180-4. PubMed ID: 6713315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dementia of Parkinson's disease and Alzheimer's disease. Is there a difference?
    Stern MB; Gur RC; Saykin AJ; Hurtig HI
    J Am Geriatr Soc; 1986 Jun; 34(6):475-8. PubMed ID: 3700936
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
    Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes.
    Rossor MN; Svendsen C; Hunt SP; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1982 Feb; 28(2):217-22. PubMed ID: 7070710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the role of the cholinergic system in human memory and cognition.
    Davies P
    Ann N Y Acad Sci; 1985; 444():212-7. PubMed ID: 3860088
    [No Abstract]   [Full Text] [Related]  

  • 17. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current concepts on the hypothesis of the cholinergic etiology of Alzheimer's disease ].
    Coralli MV; Zanotti E; Salsi A
    Recenti Prog Med; 1986 Sep; 77(9):436-9. PubMed ID: 3541087
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.